At the department of Hematology we are dedicated to improving the diagnosis and treatment of patients with hematological diseases. We perform basic and translational research to generate insight into the pathobiology of hematological diseases, and translate these findings into novel treatments for our patients.
In addition, we direct a wide variety of clinical studies, closely linked to our preclinical programs. These clinical studies deal with the development of molecular diagnostics, advancement of allogeneic stem cell transplantation, circumvention of drug-resistance to chemotherapy as well as a broad range of clinical phase I to phase III trials for a variety of hematological diseases.
For more information on clinical care for patients with hematological diseases please see our clinical homepage.
On March 26 Lauren Pickott, PhD candidate in the group of Dr Ruben Bierings, won the Dr Jeanne Stibbe Award at the annual Nederlandse Vereniging voor Trombose en Hemostase (NVTH) symposium in Koudekerke for her presentation “Studying the involvement of BLOC-2 in trafficking to lysosome related organelles using a Hermansky-Pudlak Syndrome type 5 patient model”.
Ferdows Atiq has been awarded multiple prestigious international research grants to advance the understanding of the pathophysiology, diagnosis and management of von Willebrand disease (VWD).
On 24 March, Christian Vonk successfully defended his PhD thesis entitled ‘Advancing molecular measurable residual disease detection by next-generation sequencing in acute myeloid leukemia'.
On March 26, Prof Dr Moniek de Maat, professor in the Department of Hematology of the Erasmus MC, received the Van Creveld Medal of the Dutch Society for Thrombosis and Hemostasis (NVTH).
Prof Dr Jan Cornelissen reached retirement age at the end of February and has gone into emeritus status after having worked at the Department of Hematology at Erasmus MC for 32 years.
Recently Aarazo Barakzie and Lorenzo Romano successfully defended their dissertations.
The Spring digital lecture series starts on February 9th.
Everyone is invited to attend. Registration not necessary and attendance is free of charge.
If want to be updated on our lecture series and receive the links, subscribe to our newsletter here.
The 9th workshop on “Molecular aspects of hematological malignancies” will take place on 8 and 9 June, 2026 in Rotterdam. This meeting is meant to give young investigators (PhD's or Postdocs) a platform to present their most recent work. It is a perfect moment for young investigators in our field to meet and create their own network.
You can find more information on the workshop website.
